Reliability and validity of the University of California, Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument

…, P Maranian, JR Seibold, A Impens… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To refine the previously developed scleroderma (systemic sclerosis [SSc])
gastrointestinal tract (GIT) instrument (SSC‐GIT 1.0). Methods We administered the SSC‐GIT 1.0 …

The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of …

…, C Ells, CHM Van Den Ende, M Hudson, A Impens… - BMJ open, 2013 - bmjopen.bmj.com
Introduction Psychosocial and rehabilitation interventions are increasingly used to attenuate
disability and improve health-related quality of life (HRQL) in chronic diseases, but are …

[HTML][HTML] A systematic review of social, economic and diplomatic aspects of short-term medical missions

PH Caldron, A Impens, M Pavlova, W Groot - BMC Health Services …, 2015 - Springer
Background Short-term medical missions (STMMs) represent a grass-roots form of aid,
transferring medical services rather than funds or equipment. The objective of this paper is to …

Association of gastrointestinal involvement and depressive symptoms in patients with systemic sclerosis

…, P Maranian, DE Furst, JR Seibold, A Impens… - …, 2011 - academic.oup.com
Objectives. SSc-associated gastrointestinal tract involvement (SSc-GIT) is an important
predictor of depressive symptoms. University of California at Los Angeles Scleroderma Clinical …

[HTML][HTML] Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

…, E Thirunavukkarasu, GK Haines, AJ Impens… - Arthritis research & …, 2011 - Springer
Introduction Systemic sclerosis (SSc) is characterized by fibrosis and microvascular
abnormalities including dysregulated angiogenesis. Chemokines, in addition to their …

Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis

E Schiopu, VM Hsu, AJ Impens, JA Rothman… - The Journal of …, 2009 - jrheum.org
Objective. Raynaud’s phenomenon (RP) is an important clinical feature of systemic sclerosis
(SSc) for which consistently effective therapies are lacking. The study was designed to …

Minimally important differences of the UCLA scleroderma clinical trial consortium gastrointestinal tract instrument

…, DE Furst, P Maranian, JR Seibold, A Impens… - The Journal of …, 2011 - jrheum.org
Objective. To provide minimally important difference (MID) estimates for the UCLA
Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 (UCLA SCTC GIT 2.0) in a …

[HTML][HTML] Digital ischemia in scleroderma spectrum of diseases

E Schiopu, AJ Impens, K Phillips - International journal of …, 2010 - hindawi.com
Systemic Sclerosis (Scleroderma, SSc) is a disease of unknown etiology characterized by
widespread vasculopathy and extracellular matrix deposition leading to fibrosis and …

[HTML][HTML] Economic assessment of US physician participation in short-term medical missions

PH Caldron, A Impens, M Pavlova, W Groot - Globalization and Health, 2016 - Springer
Background Short term medical missions (STMMs) are a form of unregulated and
unsanctioned, grass roots, direct medical service aid from wealthier countries to low and middle …

[PDF][PDF] Sexual activity and functioning in female scleroderma patients

AJ Impens, J Rothman, E Schiopu… - Clinical & …, 2009 - researchgate.net
Objective. Few studies exist on sexual activity and functioning in female patients with systemic
sclerosis (SSc, scleroderma). We studied the patientreported impact of SSc on sexual …